Fairvalue-Calculator Fairvalue-Calculator
EN DE

DRTECH Corporation (214680) Fair Value & Analysis

Healthcare · KR · Market cap 106B KRW

Price980.00 KRW
Fair Value1,655 KRW
Upside+68.9%
Quality95/100
Evidence: Low Range 1,241 KRW – 2,068 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DRTECH Corporation (214680) currently trades at 980.00 KRW, while our model-based Fair Value estimate is 1,655 KRW — implying the stock looks roughly 68.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

DRTECH Corporation develops and sells flat-panel X-ray detectors for digital radiography in South Korea and internationally. Its products include detectors for general radiography, mammography, dynamic, dental, veterinary, and industrial applications; imaging solutions, including specialized UI software, dual energy x-ray imaging, AI imaging processing, advanced image reconstruction technology, and AI CAD; and radiography, mammography, and C-arm systems. DRTECH Corporation was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is DRTECH Corporation (214680) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1,655 KRW versus a price of 980.00 KRW — about +69% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 214680?
Our 21-model fair value for DRTECH Corporation is 1,655 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 980.00 KRW.
What is the quality score of 214680?
DRTECH Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.